HPV Vaccination Cost Effectiveness Estimates

Nav

General Info

Email
Print

Provider

Institute for Health Metrics and Evaluation (IHME)

Geography

Afghanistan (AFG)

Albania (ALB)

Algeria (DZA)

Andorra (AND)

Angola (AGO)

Namibe

Antigua and Barbuda (ATG)

Argentina (ARG)

Armenia (ARM)

Australia (AUS)

Austria (AUT)

Azerbaijan (AZE)

Bahamas (BHS)

Bahrain (BHR)

Bangladesh (BGD)

Barbados (BRB)

Belarus (BLR)

Belgium (BEL)

Belize (BLZ)

Benin (BEN)

Bhutan (BTN)

Bolivia (BOL)

Bosnia and Herzegovina (BIH)

Botswana (BWA)

Brazil (BRA)

Brunei Darussalam (BRN)

Bulgaria (BGR)

Burkina Faso (BFA)

Burundi (BDI)

Cabo Verde (CPV)

Cambodia (KHM)

Cameroon (CMR)

Canada (CAN)

Central African Republic (CAF)

Chad (TCD)

Chile (CHL)

China (CHN)

Colombia (COL)

Comoros (COM)

Congo (COG)

Costa Rica (CRI)

Croatia (HRV)

Cuba (CUB)

Cyprus (CYP)

Czechia (CZE)

Côte d'Ivoire (CIV)

Democratic People's Republic of Korea (PRK)

Democratic Republic of the Congo (COD)

Denmark (DNK)

Djibouti (DJI)

Dominica (DMA)

Dominican Republic (DOM)

Ecuador (ECU)

Egypt (EGY)

El Salvador (SLV)

Equatorial Guinea (GNQ)

Eritrea (ERI)

Estonia (EST)

Eswatini (SWZ)

Ethiopia (ETH)

Fiji (FJI)

Åland Islands

France (FRA)

Gabon (GAB)

Gambia (GMB)

Georgia (GEO)

Germany (DEU)

Ghana (GHA)

Greece (GRC)

Greenland (GRL)

Grenada (GRD)

Guatemala (GTM)

Guinea (GIN)

Guinea-Bissau (GNB)

Guyana (GUY)

Haiti (HTI)

Honduras (HND)

Hungary (HUN)

Iceland (ISL)

India (IND)

Indonesia (IDN)

Iran (Islamic Republic of) (IRN)

Iraq (IRQ)

Ireland (IRL)

Israel (ISR)

Italy (ITA)

Jamaica (JAM)

Japan (JPN)

Jordan (JOR)

Kazakhstan (KAZ)

Kenya (KEN)

Kiribati (KIR)

Kuwait (KWT)

Kyrgyzstan (KGZ)

Lao People's Democratic Republic (LAO)

Latvia (LVA)

Lebanon (LBN)

Lesotho (LSO)

Liberia (LBR)

Libya (LBY)

Lithuania (LTU)

Luxembourg (LUX)

North Macedonia (MKD)

Madagascar (MDG)

Malawi (MWI)

Malaysia (MYS)

Maldives (MDV)

Mali (MLI)

Malta (MLT)

Marshall Islands (MHL)

Mauritania (MRT)

Mauritius (MUS)

Mexico (MEX)

Micronesia (Federated States of) (FSM)

Mongolia (MNG)

Montenegro (MNE)

Morocco (MAR)

Mozambique (MOZ)

Myanmar (MMR)

Nepal (NPL)

Netherlands (NLD)

New Zealand (NZL)

Nicaragua (NIC)

Niger (NER)

Nigeria (NGA)

Norway (NOR)

Oman (OMN)

Pakistan (PAK)

Palestine (PSE)

Panama (PAN)

Papua New Guinea (PNG)

Paraguay (PRY)

Alto Paraguay

Peru (PER)

Philippines (PHL)

Poland (POL)

Portugal (PRT)

Qatar (QAT)

Republic of Korea (KOR)

Republic of Moldova (MDA)

Romania (ROU)

Russian Federation (RUS)

Rwanda (RWA)

Saint Lucia (LCA)

Saint Vincent and the Grenadines (VCT)

Samoa (WSM)

Sao Tome and Principe (STP)

Saudi Arabia (SAU)

Senegal (SEN)

Serbia (SRB)

Seychelles (SYC)

Sierra Leone (SLE)

Singapore (SGP)

Slovakia (SVK)

Slovenia (SVN)

Solomon Islands (SLB)

Somalia (SOM)

South Africa (ZAF)

South Sudan (SSD)

Spain (ESP)

Sri Lanka (LKA)

Sudan (SDN)

Suriname (SUR)

Sweden (SWE)

Switzerland (CHE)

Syrian Arab Republic (SYR)

Taiwan (Province of China) (TWN)

Tajikistan (TJK)

Thailand (THA)

Timor-Leste (TLS)

Togo (TGO)

Tonga (TON)

Trinidad and Tobago (TTO)

Tunisia (TUN)

Turkmenistan (TKM)

Türkiye (TUR)

Uganda (UGA)

Ukraine (UKR)

United Arab Emirates (ARE)

United Kingdom (GBR)

Bermuda

United Republic of Tanzania (TZA)

United States of America (USA)

American Samoa, Guam, Northern Mariana Islands, Puerto Rico, United States Virgin Islands

Uruguay (URY)

Uzbekistan (UZB)

Vanuatu (VUT)

Venezuela (Bolivarian Republic of) (VEN)

Viet Nam (VNM)

Yemen (YEM)

Zambia (ZMB)

Zimbabwe (ZWE)

Finland (FIN)

View all

Coverage type

Global

Time period covered

12/2021 - 12/2021

Data type

Summary

The dataset contains predictions of the incremental cost-effectiveness ratios (ICERs) for the HPV vaccine in 195 countries. Predictions are based on meta-regression estimates of ICERs on three sets of independent variables (true variation measured by country characteristics, intervention characteristics, and bias variables). Data used in the meta-regression analysis are 613 ICERs from 75 studies in the Tufts University’s cost-effectiveness analysis registries, and additional extractions of ICERs for sensitivity analyses.

Keywords

HPV, HPV vaccines, Health care costs

Citation

Contributors

Institute for Health Metrics and Evaluation (IHME)

Funders

Bill and Melinda Gates Foundation (BMGF)

Publisher

Institute for Health Metrics and Evaluation (IHME)

Publication year

2021

Suggested citation

Institute for Health Metrics and Evaluation (IHME). HPV Vaccination Cost Effectiveness Estimates. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2021.

DOI

https://doi.org/10.6069/MGZ2-6413

Files (3)

Terms and conditions

Data made available for download on IHME Websites can be used, shared, modified or built upon by non-commercial users in accordance with the IHME FREE-OF-CHARGE NON-COMMERCIAL USER AGREEMENT. For more information (and inquiries about commercial use), visit IHME Terms and Conditions.

Public files

File	Size
Data Release Information Sheet	236.25 KB
HPV Vaccine Cost Effectiveness Estimates [CSV]	26.8 KB
Codebook [CSV]	13.63 KB

Code files used to produce these data

Need help downloading files?

GHDx Entry last modified on: Jan 3, 2024